KO vs LAB
The Coca-Cola Company (KO) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
KO currently screens at market cap $343.90B and trailing P/E 25.1. LAB currently screens at market cap $317.1M.
Not investment advice. Open the KO and LAB stock pages for the full models.
Not investment advice.